Catabasis Pharmaceuticals Inc
CATB
Get informed when a big investor buys or sells
+ FollowMarket Cap$234.86M
Close$
$16.12
88.7% upside
Current Fair Value
88.7% upsideUndervalued by 88.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $234.86 Million |
|---|---|
| Enterprise Value | $147.54 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.68 |
| Beta | 1.66 |
| Outstanding Shares | 0 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data